Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Rev. méd. Minas Gerais ; 24(4)out.-dez. 2014.
Article in Portuguese, English | LILACS-Express | LILACS | ID: lil-749280

ABSTRACT

O abscesso de iliopsoas (AIP) é entidade rara, podendo acometer mulheres em sua fase puerperal. Devido à anatomia peculiar do músculo iliopsoas, suas manifestações podem ser de forma insidiosa e inespecífica. Seu tratamento precoce pode diminuir significativamente a mortalidade, com base na antibioticoterapia de largo espectro e sua drenagem


Iliopsoas abscess (IPA) is a rare entity that may affect women in the puerperal stage. Due to the peculiar anatomy of the iliopsoas muscle, its manifestations can be insidious and nonspecific. Its early treatment based on broad-spectrum antibiotics and drainage can significantly decrease mortality.

2.
Clinics ; 66(10): 1699-1705, 2011. graf, tab
Article in English | LILACS | ID: lil-601902

ABSTRACT

OBJECTIVE: This study aimed to examine the association between different inflammatory markers and specific clinical endpoints in patients with febrile neutropenia. METHOD: We prospectively evaluated the expression of procalcitonin (PCT), interleukin 8 (IL-8), induced protein-10, tumor necrosis factor alpha (TNF-a), two soluble TNF-a receptors (sTNF-R I and sTNF-R II), monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1 alpha, and eotaxin in 37 episodes of febrile neutropenia occurring in 31 hospitalized adult onco-hematologic patients. Peripheral blood samples were collected in the morning at inclusion (day of fever onset) and on days 1, 3, and 7 after the onset of fever. Approximately 2-3 ml of plasma was obtained from each blood sample and stored at -80°C. RESULTS: The sTNF-R II level at inclusion (day 1), the PCT level on the day of fever onset, and the change (day 3 - day 1) in the IL-8 and eotaxin levels were significantly higher in patients who died during the 28-day follow-up. A requirement for early adjustment of antimicrobial treatment was associated with higher day 3 levels of IL-8, sTNF-R II, PCT, and MCP-1. CONCLUSION: Procalcitonin, sTNF-R II, IL-8, MCP-1, and eotaxin could potentially be used to assess the risk of death and the requirement for early adjustment of antimicrobial treatment in febrile, neutropenic onco-hematologic patients. The levels of the other markers showed no association with any of the evaluated endpoints.


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Calcitonin/blood , Neutropenia/blood , Protein Precursors/blood , Biomarkers/blood , C-Reactive Protein/metabolism , Cause of Death , /blood , /blood , /blood , Epidemiologic Methods , Inflammation/blood , /blood , /blood , Neutropenia/mortality , Prospective Studies , Receptors, Tumor Necrosis Factor, Type I/blood , Time Factors , Tumor Necrosis Factor-alpha/blood
SELECTION OF CITATIONS
SEARCH DETAIL